ZYUS Life Sciences Corporation Announces Planned Release Date for Phase 2a Clinical Trial Results, Annual General Meeting Results and Change in Audit Committee Chair

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/SASKATOON, SK, Sept. 24, 2026 /CNW/ -- ZYUS Life Sciences Corporation (the "ZYUS" and or "Company") (TSXV:ZYUS), a clinical-stage life sciences company focused on the development and commercialization…